Back to search
FDAFDA · Food and drugs·Recall number Z-1660-2018

Dimension Vista Thyroxine (T4) assay; (Product Number: K6065/10445101) (Mfr: Siemens Healthcare Diagnostics, Newark, DE)

Published May 16, 2018 · Recall initiated: June 29, 2017

Summary

FDA records medical device Class II recall Z-1660-2018, published May 16, 2018 and initiated June 29, 2017. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: 19,991; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
Distributed in all 50 U.S. states, the District of Columbia, Guam, and Puerto Rico. Distributed in 108 foreign countries: Afghanistan Bolivia Albania®¿¿¿¿¿¿¿ Algeria®¿¿¿¿¿¿¿ Angola ARGENTINA Armenia AUSTRALIA Austria®¿¿¿¿¿¿¿ Azerbaijan Bahamas Bahrain®¿¿¿¿¿¿¿ Bangladesh®¿¿¿¿ Belarus®¿¿¿¿¿¿¿ Belgium®¿¿¿¿¿¿¿ Bosnia®Herzeg.¿ Brazil Bulgaria®¿¿¿¿¿¿ Cambodia Canada Canary islands Chile China Colombia Costa Rica Croatia®¿¿¿¿¿¿¿ Cyprus®¿¿¿¿¿¿¿¿ Czech®Republic® Denmark®¿¿¿¿¿¿¿ Ecuador Egypt®¿¿¿¿¿¿¿¿¿ El Salavador Estonia®¿¿¿¿¿¿¿ Finland®¿¿¿¿¿¿¿ France®¿¿¿¿¿¿¿¿ Georgia Germany®¿¿¿¿¿¿¿ Greece®¿¿¿¿¿¿¿¿ Guatemala Honduras Hong Kong Hungary®¿¿¿¿¿¿¿ Iceland India Indonesia Iraq Ireland®¿¿¿¿¿¿¿ Israel®¿¿¿¿¿¿¿¿ Italy®¿¿¿¿¿¿¿¿¿ japan Jordan Kazakhstan®¿¿¿¿ Korea Kuwait Latvia®¿¿¿¿¿¿¿¿ Lebanon Lithuania®¿¿¿¿¿ Luxembourg®¿¿¿¿ Macedonia Malaysia Mali Malta®¿¿¿¿¿¿¿¿¿ Mexico Morocco®¿¿¿¿¿¿¿ Myanmar Nepal Netherlands®¿¿¿ New Zealand Nicaragua Norway®¿¿¿¿¿¿¿¿ Oman Pakistan®¿¿¿¿¿¿ Paraguay Peru Philippines Poland®¿¿¿¿¿¿¿¿ Portugal®¿¿¿¿¿¿ Qatar®¿¿¿¿¿¿¿¿¿ Romania®¿¿¿¿¿¿¿ Russian®Fed.¿¿¿ Saudi Arabia Senegal Serbia®¿¿¿¿¿¿¿¿ Serbia®¿¿¿¿¿¿¿¿ Singapore Slovakia®¿¿¿¿¿¿ Slovenia®¿¿¿¿¿¿ South Africa South Africa South Korea Spain®¿¿¿¿¿¿¿¿¿ Sri Lanka Sweden®¿¿¿¿¿¿¿¿ Switzerland®¿¿¿ Taiwan®¿¿¿¿¿¿¿¿ Tajikistan Thailand Tunisia®¿¿¿¿¿¿¿ Turkey®¿¿¿¿¿¿¿¿ Turkmenistan®¿¿ United Arab Emerites®¿¿¿¿¿ United®Kingdom® Uruguay®¿¿¿¿¿¿¿ Uzbekistan Vatikancity®¿¿¿ Venezuela Vietnam Yemen
Lot
All lots
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Dimension Vista Thyroxine (T4) assay; (Product Number: K6065/10445101) (Mfr: Siemens Healthcare Diagnostics, Newark, DE) recalled?

Yes. FDA published recall Z-1660-2018 on May 16, 2018. Reported hazard: Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail